Research location
Montreal
Canada
Advertisement
Research activity in Montreal
CanadaCureCurrent currently publishes aggregate city-level research activity for this location: 235 trials and 313 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Montreal
235 linked trials · page 1 of 5A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic DiseasesNCT07304154 · 2026-04-10 · 1 site observation
RECRUITING
A Study of Brenipatide in Adult Participants With Major Depressive DisorderNCT07412756 · 2026-02-09 · 1 site observation
RECRUITING
Axillary Radiotherapy or Axillary Lymph Node Dissection in Patients With Clinically Node- Positive Breast Cancer Undergoing Upfront Tailored Axillary SurgeryNCT07140172 · 2026-01-01 · 1 site observation
RECRUITING
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe AsthmaNCT07219173 · 2025-10-22 · 1 site observation
RECRUITING
A Study to Evaluate ALN-5288 in Patients With Alzheimer's DiseaseNCT07214727 · 2025-10-15 · 1 site observation
RECRUITING
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular DiseaseNCT07181109 · 2025-09-22 · 2 site observations
RECRUITING
A Study of LY4257496 in Participants With Cancer (OMNIRAY)NCT07114601 · 2025-08-06 · 1 site observation
RECRUITING
A Study of LY4256984 in Participants With Sporadic Amyotrophic Lateral SclerosisNCT07100119 · 2025-08-05 · 1 site observation
RECRUITING
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or OverweightNCT06937099 · 2025-06-26 · 1 site observation
RECRUITING
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b StudyNCT06937086 · 2025-06-26 · 1 site observation
RECRUITING
Study of Sacituzumab Govitecan Versus Standard of Care in Participants With Previously Treated Extensive Stage Small Cell Lung CancerNCT06801834 · 2025-04-04 · 1 site observation
RECRUITING
Glycemic Control and Osteohealth in Adults Living With Type 1 DiabetesNCT06158503 · 2025-02-01 · 1 site observation
RECRUITING
Support-t Online Training in Youth Living With Type 1 Diabetes Transitioning to Adult CareNCT05910840 · 2024-10-07 · 1 site observation
RECRUITING
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast CancerNCT06435429 · 2024-08-13 · 1 site observation
RECRUITING
Fibrosis Lessens After Metabolic SurgeryNCT06374875 · 2024-07-11 · 1 site observation
RECRUITING
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart FailureNCT06424288 · 2024-06-17 · 2 site observations
RECRUITING
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)NCT05485961 · 2024-04-27 · 2 site observations
RECRUITING
Left vs Left Randomized Clinical TrialNCT05650658 · 2023-09-13 · 1 site observation
RECRUITING
The ReTAVI Prospective Observational RegistryNCT05601453 · 2023-09-05 · 1 site observation
RECRUITING
The LYMPH Trial - Microsurgical Versus Conservative Treatment of Chronic Breast Cancer Associated LymphedemaNCT05890677 · 2023-07-14 · 1 site observation
RECRUITING
Do "sugar Swings" Impact the Brain Function and the Eating Behaviors of People with Type 1 DiabetesNCT05487534 · 2023-04-26 · 1 site observation
RECRUITING
A Study to Evaluate the Safety and Tolerability of ALN-APP in Patients With EOADNCT05231785 · 2022-02-04 · 1 site observation
RECRUITING
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung CancerNCT04614103 · 2021-05-07 · 1 site observation
RECRUITING
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 DiabetesNCT04786262 · 2021-03-29 · 1 site observation
RECRUITING
EORTC Metastatic Breast Cancer Module DevelopmentNCT07806266 · 2020-05-01 · 1 site observation
RECRUITING
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid TumorsNCT03175224 · 2017-09-27 · 1 site observation
RECRUITING
TSC Biosample Repository and Natural History DatabaseNCT05676099 · 2016-01-01 · 2 site observations
RECRUITING
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy ProductsNCT00271180 · 1983-01-01 · 1 site observation
RECRUITING
18F-FDG PET/CT for Diagnosis of Diabetic Foot OsteomyelitisNCT07828691 · 2026-11-01 · 3 site observations
NOT_YET_RECRUITING
Stratification and Treatment in Early Psychosis Study - PROMOTENCT07434973 · 2026-05-01 · 1 site observation
NOT_YET_RECRUITING
A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or OverweightNCT06962280 · 2025-05-12 · 1 site observation
ACTIVE_NOT_RECRUITING
ASCEND CSP IDE StudyNCT06830746 · 2025-04-11 · 1 site observation
ACTIVE_NOT_RECRUITING
Study of Eftilagimod Alfa (Efti) in Combination With Pembrolizumab and Chemotherapy Versus Placebo in Combination With Pembrolizumab and Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (NSCLC) (TACTI-004)NCT06726265 · 2025-03-21 · 1 site observation
ACTIVE_NOT_RECRUITING
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0NCT06823115 · 2025-03-01 · 1 site observation
ENROLLING_BY_INVITATION
A Study of Remternetug (LY3372993) in Early Alzheimer's Disease (TRAILRUNNER-ALZ 3)NCT06653153 · 2024-10-24 · 2 site observations
ACTIVE_NOT_RECRUITING
Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory PolyneuropathyNCT06568042 · 2024-08-22 · 1 site observation
COMPLETED
The OPBC-07/microNAC StudyNCT06529302 · 2024-05-15 · 1 site observation
ACTIVE_NOT_RECRUITING
[Ac-225]-PSMA-62 Trial in Oligometastatic Hormone Sensitive and Metastatic Castration Resistant Prostate CancerNCT06229366 · 2024-04-03 · 2 site observations
ACTIVE_NOT_RECRUITING
Zilebesiran as Add-on Therapy in Patients With High Cardiovascular Risk and Hypertension Not Adequately Controlled by Standard of Care Antihypertensive Medications (KARDIA-3)NCT06272487 · 2024-02-29 · 2 site observations
COMPLETED
A Phase III Randomised Study to Evaluate Dato-DXd and Durvalumab for Neoadjuvant/Adjuvant Treatment of Triple-Negative or Hormone Receptor-low/HER2-negative Breast CancerNCT06112379 · 2023-11-14 · 1 site observation
ACTIVE_NOT_RECRUITING
A Safety, Tolerability, and Efficacy Study of VX-264 in Participants With Type 1 DiabetesNCT05791201 · 2023-05-16 · 1 site observation
ACTIVE_NOT_RECRUITING
Nodal Burden and Nodal Recurrence in Patients With Isolated Tumor Cells After Neoadjuvant Chemotherapy Treated With Axillary Dissection or Nodal Radiation: the OPBC-05/EUBREAST-14R/ICARO StudyNCT06464341 · 2023-05-04 · 1 site observation
COMPLETED
A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With ObesityNCT05556512 · 2022-10-11 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study of Imlunestrant Versus Standard Endocrine Therapy in Participants With Early Breast CancerNCT05514054 · 2022-10-04 · 3 site observations
ACTIVE_NOT_RECRUITING
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice and Pembrolizumab in Patients With Previously Untreated, Locally Advanced Inoperable or Metastatic Triple-Negative Breast CancerNCT05382286 · 2022-07-25 · 2 site observations
ACTIVE_NOT_RECRUITING
Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON)NCT05153239 · 2022-07-22 · 1 site observation
COMPLETED
Study of Sacituzumab Govitecan-hziy Versus Treatment of Physician's Choice in Patients With Previously Untreated Locally Advanced Inoperable or Metastatic Triple-Negative Breast CancerNCT05382299 · 2022-07-20 · 2 site observations
ACTIVE_NOT_RECRUITING
Open-label Study of Adjunctive GNX Treatment in Children and Adults With TSC-related EpilepsyNCT05604170 · 2022-05-16 · 2 site observations
TERMINATED
Adjunctive GNX Treatment Compared With Placebo in Children and Adults With TSC-related EpilepsyNCT05323734 · 2022-04-01 · 2 site observations
COMPLETED
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic AlterationsNCT05215340 · 2022-03-04 · 1 site observation
ACTIVE_NOT_RECRUITING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.